Genome Editing Using CRISPR-Cas Systems: Development and Prospects-Feng Zhang

Поделиться
HTML-код
  • Опубликовано: 28 дек 2024

Комментарии •

  • @cielotempestoso7838
    @cielotempestoso7838 3 года назад +1

    Sei rozzo ma spieghi facile ! Bravo

    • @Scasco326
      @Scasco326 Год назад

      Commento assolutamente necessario e apprezzato

  • @davemyers9650
    @davemyers9650 8 лет назад +4

    This technology is extremely valuable. Worth 10's of billions. Editas market cap will be 200 billion in 10 years. Much more valuable than any social media company. So several hundred billion market cap is expected.
    This is the most powerful technology on the planet.

    • @wuschelbeutel
      @wuschelbeutel 7 лет назад

      if they win in appeals, dont get leapfrogged by a big player or competitor (which may use another protein), dont get blocked by regulatory hurdles, find a suitable delivery mechanism of the system, get reliable and accurate modifications, conduct successful clinical trials, stay afloat with funding..., yeah then maybe

    • @paolotomasello9745
      @paolotomasello9745 7 лет назад

      wuschelbeutel santagsltrudecomensoli